Literature DB >> 18850049

Design of peptide inhibitors for furin based on the C-terminal fragment of histone H1.2.

Suming Wang1, Jinbo Han, Yanfang Wang, Wuyuan Lu, Chengwu Chi.   

Abstract

The mammalian proprotein convertase furin has been found to play an important role in diverse physiological and pathological events, such as the activation of viral glycoproteins and bacterial exotoxins. Small, non-toxic and highly active, furin inhibitors are considered to be attractive drug candidates for diseases caused by virus and bacteria. In this study, a series of peptide inhibitors were designed and synthesized based on the C-terminal fragment of histone H1.2, which has an inhibitory effect on furin. Replacing the reactive site of inhibitors with the consensus substrate recognition sequence of furin has been found to increase inhibitory activity greatly. The most potent inhibitor, I4, with 14 amino acid residues has a Ki value of 17 nM for furin. Although most of the synthesized peptides were temporary inhibitors, the inhibitor I5, with nine amino acids, retained its full potency, even after a 3 h incubation period with furin at 37 degrees C. These inhibitors may potentially lead to the development of anti-viral and anti-bacterial drug compounds.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18850049      PMCID: PMC7110110     

Source DB:  PubMed          Journal:  Acta Biochim Biophys Sin (Shanghai)        ISSN: 1672-9145            Impact factor:   3.848


  43 in total

Review 1.  Furin at the cutting edge: from protein traffic to embryogenesis and disease.

Authors:  Gary Thomas
Journal:  Nat Rev Mol Cell Biol       Date:  2002-10       Impact factor: 94.444

2.  Epithelial sodium channels are activated by furin-dependent proteolysis.

Authors:  Rebecca P Hughey; James B Bruns; Carol L Kinlough; Keri L Harkleroad; Qiusheng Tong; Marcelo D Carattino; John P Johnson; James D Stockand; Thomas R Kleyman
Journal:  J Biol Chem       Date:  2004-03-07       Impact factor: 5.157

3.  The potent inhibitory activity of histone H1.2 C-terminal fragments on furin.

Authors:  Jinbo Han; Ling Zhang; Xiaoxia Shao; Jiahao Shi; Chengwu Chi
Journal:  FEBS J       Date:  2006-09-05       Impact factor: 5.542

4.  The yeast CLC chloride channel is proteolytically processed by the furin-like protease Kex2p in the first extracellular loop.

Authors:  Andrea Wächter; Blanche Schwappach
Journal:  FEBS Lett       Date:  2005-02-14       Impact factor: 4.124

5.  Engineered eglin c variants inhibit yeast and human proprotein processing proteases, Kex2 and furin.

Authors:  T Komiyama; R S Fuller
Journal:  Biochemistry       Date:  2000-12-12       Impact factor: 3.162

6.  Inhibition of furin by polyarginine-containing peptides: nanomolar inhibition by nona-D-arginine.

Authors:  Magdalena M Kacprzak; Juan R Peinado; Manuel E Than; Jon Appel; Stefan Henrich; Gregory Lipkind; Richard A Houghten; Wolfram Bode; Iris Lindberg
Journal:  J Biol Chem       Date:  2004-06-14       Impact factor: 5.157

7.  Polyarginine inhibits gp160 processing by furin and suppresses productive human immunodeficiency virus type 1 infection.

Authors:  Karen V Kibler; Akiko Miyazato; Venkat S R K Yedavalli; Andrew I Dayton; Bertram L Jacobs; George Dapolito; Seong-jin Kim; Kuan-Teh Jeang
Journal:  J Biol Chem       Date:  2004-09-14       Impact factor: 5.157

8.  Changing the inhibitory specificity and function of the proteinase inhibitor eglin c by site-directed mutagenesis: functional and structural investigation.

Authors:  D W Heinz; S G Hyberts; J W Peng; J P Priestle; G Wagner; M G Grütter
Journal:  Biochemistry       Date:  1992-09-22       Impact factor: 3.162

9.  Anthrax toxin protective antigen is activated by a cell surface protease with the sequence specificity and catalytic properties of furin.

Authors:  K R Klimpel; S S Molloy; G Thomas; S H Leppla
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

10.  Optimization of protease-inhibitor interactions by randomizing adventitious contacts.

Authors:  Tomoko Komiyama; Bryan VanderLugt; Martin Fugère; Robert Day; Randal J Kaufman; Robert S Fuller
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-27       Impact factor: 12.779

View more
  1 in total

1.  A novel enediynyl peptide inhibitor of furin that blocks processing of proPDGF-A, B and proVEGF-C.

Authors:  Ajoy Basak; Abdel-Majid Khatib; Dayani Mohottalage; Sarmistha Basak; Maria Kolajova; Subhendu Sekhar Bag; Amit Basak
Journal:  PLoS One       Date:  2009-11-26       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.